Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD
Jonathan M. Meyer
Advances in Managing Neuropsychiatric Symptoms of Alzheimer’s Disease: From Early Detection to Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Advancing Care: Clinical Innovations on the Horizon
John Vissing, MD, DMSci
Bridging Gaps in LGMD Care
Conrad Weihl, MD, PhD
Navigating the LGMD2I/R9 Diagnostic Pathway
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
James R. Bateman, MD, MPH
Jerome A. Barakos, MD
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
B. Joy Snider, MD, PhD
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Charles P. Vega, MD
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
Ahmed Z. Obeidat, MD, PhD
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Balancing Act: Immune Reconstitution vs Immune Suppression
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.